Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

Bibliographic Details
Main Authors:	S. Tiberi, L. DâAmbrosio, R. Centis, G.B. Migliori
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S120197121730276X

Similar Items

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.
Published: (2012-02-01)

Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil
by: M.A. Arbex, et al.
Published: (2016-11-01)

Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
by: Hyun Lee, et al.
Published: (2017-12-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Tuberculosis: an ancient and evergreen disease
by: G.B. Migliori, et al.
Published: (2011-06-01)

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
by: Frederick A Sirgel, et al.
Published: (2013-01-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.
by: Frederick A Sirgel, et al.
Published: (2015-01-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al.

A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis
by: Manse Kim, et al.
Published: (2022-08-01)

rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
by: Li MC, et al.
Published: (2022-11-01)

Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
by: Wei Jing, et al.
Published: (2017-09-01)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
by: Sandeep Sharma, et al.
Published: (2017-11-01)

Comments regarding use of rifabutin for eradication
by: David Y. Graham
Published: (2021-10-01)

Tuberculosis, one disease, many faces
by: G.B. Migliori, et al.
Published: (2016-01-01)

Acquisition of rifabutin resistance by a rifampicin resistant mutant of <it>Mycobacterium tuberculosis </it>involves an unusual spectrum of mutations and elevated frequency
by: Oskam Linda, et al.
Published: (2005-06-01)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
by: Emanuele Pontali, et al.
Published: (2019-05-01)

Book review: Tuberculosis: The Essentials. Fourth edition
by: G.B. Migliori
Published: (2011-06-01)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
by: Mohammad Javad Nasiri, et al.
Published: (2022-11-01)

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
by: Joanitah Nalunjogi, et al.
Published: (2023-05-01)

Post-Tuberculosis (TB) Treatment: The Role of Surgery and Rehabilitation
by: Dina Visca, et al.
Published: (2020-04-01)

Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan
by: Chia-Jung Kuo, et al.
Published: (2024-01-01)

Diagnosis and treatment of multidrug-resistant tuberculosis
by: Jong Geol Jang, et al.
Published: (2020-10-01)

A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
by: Miranda Monk, et al.
Published: (2022-06-01)

New treatment options for multidrug-resistant tuberculosis
by: Stephen K. Field, et al.
Published: (2012-10-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Nano-Rifabutin entrapment within glucan microparticles enhances protection against intracellular Mycobacterium tuberculosis
by: Tarun K. Upadhyay, et al.
Published: (2019-12-01)

Rifabutin for the Treatment of <i>Helicobacter pylori</i> Infection: A Review
by: Javier P. Gisbert
Published: (2020-12-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

Rifabutin Use in <i>Staphylococcus</i> Biofilm Infections: A Case Series
by: James B. Doub, et al.
Published: (2020-06-01)

Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay
by: Ming-Chih Yu, et al.
Published: (2022-08-01)

New Leads for the Treatment of Multidrug Resistant Mycobacterium tuberculosis
by: Seth B. Herzon
Published: (2020-06-01)

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin
by: A. P. Kaplun, et al.
Published: (2010-04-01)

Multidrug-resistant tuberculosis
by: Antônio Carlos Moreira Lemos, et al.
Published: (2013-04-01)

Multidrug-resistant tuberculosis
by: McNerney Ruth, et al.
Published: (2008-01-01)

Multidrug-resistant tuberculosis
by: Antônio Carlos Moreira Lemos, et al.

Multidrug-resistant tuberculosis
by: Antônio Carlos Moreira Lemos, et al.
Published: (2013-03-01)

Multidrug-resistant tuberculosis
by: Álvarez-Gaviria Manuel, et al.
Published: (2013-06-01)